Clinical trials: Prophylactic Tranexamic Acid Use
Lung Transplant, Complications Surgical
Protest Trial: TXA vs Saline
To determine if endobronchial (topical) tranexamic acid used prophylactically prior to performing transbronchial biopsies in lung transplant recipients reduces bleeding risk.
- Trial name
- NCT06422273
- Testing
- Tranexamic Acid
- Where
- United States
- Volunteers
- 94 people
- Sponsor
- Corewell Health West
Postpartum Haemorrhage
Topical Tranexamic Acid in Caesarean Section
The objective of this study is to investigate whether topical application of tranexamic acid into the uterine cavity and the surgical site intra-operatively can reduce blood loss and provide better surgical haemostasis in…
- Trial name
- TXACS (NCT02492087)
- Testing
- Topical tranexamic acid, Normal saline 0.9%
- Where
- Malaysia
- Volunteers
- 84 people
- Sponsor
- Dr Meng-Li Lee
Abortion, Dilation and Evacuation
Tranexamic Acid for Second Trimester Dilation and Evacuation and Bleeding Outcomes
Although procedural abortion in the second trimester is extremely safe, hemorrhage is one of the leading causes of morbidity and mortality.
- Conditions
- Abortion, Dilation and Evacuation, Hemorrhage, Prophylactic Tranexamic Acid Use
- Trial name
- NCT06820177
- Testing
- Tranexamic Acid
- Where
- 3 sites in United States
- Volunteers
- 276 people, healthy volunteers welcome
- Sponsor
- University of California, San Diego
Fibroid Uterus, Abnormal Uterine Bleeding
Prophylactic Tranexamic Acid During Minimally Invasive Myomectomies
This is a Double-blinded randomized placebo-controlled trial based at Eastern Virginia Medical School. Subjects who are identified in clinic having menorrhagia or abnormal Uterine bleeding (AUB) due to uterine fibroids and meet…
- Conditions
- Fibroid Uterus, Abnormal Uterine Bleeding, Myoma;Uterus
- Trial name
- NCT04311073
- Testing
- Tranexamic Acid
- Where
- United States
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Eastern Virginia Medical School
Postpartum Hemorrhage, Vaginal Delivery
Prophylactic Tranexamic Acid Use After Vaginal Delivery
In this study, our aim was to evaluate the effectiveness of prophylactic tranexamic acid use after vaginal delivery in pregnant women aged 18-45 years and 34-42 weeks according to the risk of postpartum hemorrhage.
- Conditions
- Postpartum Hemorrhage, Vaginal Delivery, Prophylactic Tranexamic Acid Use
- Trial name
- NCT05429580
- Testing
- Tranexamic acid, 5% Dextrose
- Where
- Turkey (Türkiye)
- Volunteers
- 480 people, healthy volunteers welcome
- Sponsor
- Sanliurfa Mehmet Akif Inan Education and Research Hospital
Post Partum Hemorrhage
Use of TXA to Prevent Postpartum Hemorrhage
Postpartum hemorrhage (PPH) occurs in up to one in ten deliveries worldwide and is the leading cause of maternal morbidity and mortality.
- Trial name
- TAPPH-1 (NCT03069859)
- Testing
- TXA (1g)
- Where
- Canada
- Volunteers
- 31 people
- Sponsor
- Sunnybrook Health Sciences Centre